Omnipod 5 App 1.1.6

The Omnipod® 5 represents a significant advancement in diabetes management as the only FDA-cleared, tubeless automated insulin delivery system that seamlessly integrates with the Dexcom G6 continuous glucose monitor (CGM). This innovative system automates insulin delivery, eliminating the need for multiple daily injections and reducing reliance on fingerstick blood glucose monitoring, although fingersticks are still essential for treatment decisions when symptoms or expectations differ from readings.

Central to the Omnipod 5 System's functionality is its combination of the Omnipod 5 Pod and the Omnipod 5 App, which can be accessed via an Insulet-provided controller or a compatible personal smartphone. The integration with the Dexcom G6 CGM enhances real-time glucose management, allowing users to proactively manage their insulin needs.

The Omnipod 5 App facilitates user control by providing features such as basal profile selection, target glucose setting, bolus delivery, and Pod activation and deactivation. This streamlined app offers an intuitive interface that simplifies the user experience while ensuring accurate insulin delivery.

Intended for individuals aged 2 years and older with Type 1 diabetes mellitus and adults with Type 2 diabetes, the Omnipod 5 System is designed for single patient use at home and requires a prescription. Compatibility extends to U-100 insulins like NovoLog®, Humalog®, and Admelog®.

It is imperative to refer to the Omnipod® 5 Automated Insulin Delivery System User Guide for comprehensive safety information, including indications, contraindications, and operational instructions. Users are encouraged to undergo proper training before utilizing the app, as it should not serve as a primary resource for technical or customer support issues. For assistance, users should contact Insulet customer support to ensure effective resolution of any concerns while safeguarding their privacy.

As a reminder, it is crucial to consult a healthcare professional regarding any medical decisions in conjunction with app usage.